Search results
Results from the WOW.Com Content Network
An International Nonproprietary Name (INN) is an official generic and nonproprietary name given to a pharmaceutical substance or an active ingredient, [1] encompassing compounds, peptides and low-molecular-weight proteins (e.g., insulin, hormones, cytokines), as well as complex biological products, such as those used for gene therapy. [2]
The World Health Organization (WHO) introduced the system of International Nonproprietary Names in 1950, with the first INN list being published three years later. The stem -mab for monoclonal antibodies was proposed around 1990, and the current system with target and source substems was developed between 1991 and 1993. Due to the collaboration ...
The USAN Council began in June 1961 after the AMA and the USP jointly formed the AMA-USP Nomenclature Committee. [3] The American Pharmacists Association (APhA) became the third sponsoring organization in 1964, at which point the name of the committee was changed to the USAN Council, and United States Adopted Name became the official term to describe any nonproprietary name negotiated and ...
FREE Resources: 3 articles every 2 weeks (Register and Read Program, archived journals). Also, early journals (prior to 1923 in US, 1870 elsewhere) free, no registry necessary. Free and Subscription JSTOR [89] Jurn: Multidisciplinary Jurn is a free-to-use online search tool for finding and downloading free full-text scholarly works.
Neluxicapone (INN Tooltip International Nonproprietary Name) is a catechol O-methyltransferase (COMT) inhibitor which has not been marketed as of 2024. [1] [2] [3] The drug is a nitrocatechol and is structurally related to other catechol COMT inhibitors like entacapone, tolcapone, and nebicapone.
Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International nonproprietary name; BAN = British Approved Name; USAN = United States Adopted Name; Two-letter codes for countries
A Japanese Accepted Name (Japanese: 日本医薬品一般的名称, Hepburn: Nihon Iyakuhin Ippan-teki Meishō) (JAN) is the official non-proprietary or generic name given to a pharmaceutical substance by the Government of Japan.
Ioflupane (123 I) is the international nonproprietary name (INN) of a cocaine analogue which is a neuro-imaging radiopharmaceutical drug, used in nuclear medicine for the diagnosis of Parkinson's disease and the differential diagnosis of Parkinson's disease over other disorders presenting similar symptoms.